+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Leukapheresis Market by Type (Leukapheresis Devices, Leukapheresis Disposables), Application (Research Applications, Therapeutic Applications), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5322961
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Leukapheresis Market size was estimated at USD 56.21 million in 2023, USD 61.62 million in 2024, and is expected to grow at a CAGR of 9.71% to reach USD 107.58 million by 2030.The leukapheresis includes the products, devices, procedures, and services related to selectively removing white blood cells (leukocytes) from a patient's or donor's blood. It encompasses different types of leukapheresis procedures, such as autologous leukapheresis and allogeneic leukapheresis, which are applied across various therapeutic areas, including cancer treatment, hematopoietic stem cell transplantation (HSCT), chronic inflammatory diseases management, and immune system regulation. The expanding geriatric population increases the demand for leukapheresis treatments due to their increased susceptibility to age-related diseases. However, the high costs associated with devices and consumables necessary for leukapheresis pose significant barriers for patients and healthcare providers. Nevertheless, ongoing clinical trials exploring novel applications of leukapheresis-derived cells in areas including regenerative medicine present potential opportunities for the leukapheresis market.

Regional Insights

The leukapheresis market is evolving in the Americas with robust healthcare infrastructure, increasing prevalence of leukemia, and adoption of advanced technologies. The European Union (EU) has shown a growing demand for leukapheresis products due to rising incidences of blood disorders. In the EMEA region, increased awareness about leukemia treatment options and improved healthcare infrastructure drive demand for leukapheresis products. The Asia Pacific region represents significant growth in the leukapheresis market due to increased healthcare expenditure, growing awareness of blood disorders, and advancements in healthcare technology. Besides, advancements in leukapheresis devices are anticipated to improve treatment outcomes and encourage their deployment across end-use sectors globally.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Leukapheresis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Leukapheresis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Leukapheresis Market, highlighting leading vendors and their innovative profiles. These include Allcells, LLC, Asahi Kasei Corporation, Beijing Zksk Technology Co. Ltd., Bioivt, Caltag Medsystems Limited, Charles River Laboratories International, Inc., Discovery Life Sciences, Fresenius Se & Co. Kgaa, Guangzhou Daji Medical Science and Technology Co. Ltd., Haemonetics Corporation, Intelligent Tissue Group, Lonza Group Ag, Macopharma Sa, Medica Spa., Miltenyi Biotec, Precision for Medicine, Inc., Puriblood Medical Co. Ltd., Stemexpress, LLC, Terumo BCT, and Zenbio, Inc.

Market Segmentation & Coverage

This research report categorizes the Leukapheresis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Leukapheresis Devices
      • Centrifugal Devices
      • Membrane Separators
    • Leukapheresis Disposables
  • Application
    • Research Applications
    • Therapeutic Applications
  • End-User
    • Academic & Research Institutes
    • Blood Component Providers & Blood Centers
    • Contract Research Organizations
    • Hospitals & Transfusion Centers
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Leukapheresis Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Leukapheresis Market?
  3. What are the technology trends and regulatory frameworks in the Leukapheresis Market?
  4. What is the market share of the leading vendors in the Leukapheresis Market?
  5. Which modes and strategic moves are suitable for entering the Leukapheresis Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Frequently Asked Questions about the Global Leukapheresis Market

What is the estimated value of the Global Leukapheresis Market?

The Global Leukapheresis Market was estimated to be valued at $61.62 Million in 2024.

What is the growth rate of the Global Leukapheresis Market?

The growth rate of the Global Leukapheresis Market is 9.7%, with an estimated value of $107.58 Million by 2030.

What is the forecasted size of the Global Leukapheresis Market?

The Global Leukapheresis Market is estimated to be worth $107.58 Million by 2030.

Who are the key companies in the Global Leukapheresis Market?

Key companies in the Global Leukapheresis Market include Allcells, LLC, Asahi Kasei Corporation, Beijing Zksk Technology Co. Ltd., Bioivt, Caltag Medsystems Limited, Charles River Laboratories International, Inc., Discovery Life Sciences, Fresenius Se & Co. Kgaa, Guangzhou Daji Medical Science and Technology Co. Ltd. and Haemonetics Corporation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Leukapheresis Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing application in cancer therapy
5.1.1.2. Demand for leukapheresis in clinical research
5.1.1.3. Growth in initiatives for blood donations
5.1.2. Restraints
5.1.2.1. High cost of procedure
5.1.3. Opportunities
5.1.3.1. Focus and investment in R&D activities
5.1.3.2. Leukapheresis for CAR or Adoptive Cell Therapy
5.1.4. Challenges
5.1.4.1. Potential issues related to leukapheresis including discomfort, redness, and bruising
5.2. Market Segmentation Analysis
5.2.1. Type: Increasing use of leukapheresis devices for efficient separation of white blood cells
5.2.2. Application: Rising application of leukapheresis in therapeutics for improved patient outcome
5.2.3. End-User: Proliferating use of leukapheresis devices by blood component providers & blood centers
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Leukapheresis Market, by Type
6.1. Introduction
6.2. Leukapheresis Devices
6.3.1. Centrifugal Devices
6.3.2. Membrane Separators
6.3. Leukapheresis Disposables
7. Leukapheresis Market, by Application
7.1. Introduction
7.2. Research Applications
7.3. Therapeutic Applications
8. Leukapheresis Market, by End-User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Blood Component Providers & Blood Centers
8.4. Contract Research Organizations
8.5. Hospitals & Transfusion Centers
8.6. Pharmaceutical & Biotechnology Companies
9. Americas Leukapheresis Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Leukapheresis Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Leukapheresis Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. SCTbio Partners With Cyto-Care To Improve Cell Therapy Cryopreservation
12.3.2. New Product Launch & Enhancement
12.3.2.1. Akadeum Launches T Cell Activation and Expansion Using Positive Selection and Expands Leukopak Cell Isolation Product Lines
12.3.2.2. Fresenius Kabi Launches Single-Needle Option for the Amicus Extracorporeal Photopheresis Protocol
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Allcells, LLC
13.1.2. Asahi Kasei Corporation
13.1.3. Beijing Zksk Technology Co. Ltd.
13.1.4. Bioivt
13.1.5. Caltag Medsystems Limited
13.1.6. Charles River Laboratories International, Inc.
13.1.7. Discovery Life Sciences
13.1.8. Fresenius Se & Co. Kgaa
13.1.9. Guangzhou Daji Medical Science and Technology Co. Ltd.
13.1.10. Haemonetics Corporation
13.1.11. Intelligent Tissue Group
13.1.12. Lonza Group Ag
13.1.13. Macopharma Sa
13.1.14. Medica Spa.
13.1.15. Miltenyi Biotec
13.1.16. Precision for Medicine, Inc.
13.1.17. Puriblood Medical Co. Ltd.
13.1.18. Stemexpress, LLC
13.1.19. Terumo BCT
13.1.20. Zenbio, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. LEUKAPHERESIS MARKET RESEARCH PROCESS
FIGURE 2. LEUKAPHERESIS MARKET SIZE, 2023 VS 2030
FIGURE 3. LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. LEUKAPHERESIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. LEUKAPHERESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. LEUKAPHERESIS MARKET DYNAMICS
FIGURE 7. LEUKAPHERESIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. LEUKAPHERESIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. LEUKAPHERESIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. LEUKAPHERESIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. LEUKAPHERESIS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. LEUKAPHERESIS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. LEUKAPHERESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LEUKAPHERESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 8. LEUKAPHERESIS MARKET SIZE, BY CENTRIFUGAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. LEUKAPHERESIS MARKET SIZE, BY MEMBRANE SEPARATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. LEUKAPHERESIS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. LEUKAPHERESIS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 15. LEUKAPHERESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. LEUKAPHERESIS MARKET SIZE, BY BLOOD COMPONENT PROVIDERS & BLOOD CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. LEUKAPHERESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. LEUKAPHERESIS MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. LEUKAPHERESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. CANADA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 35. CANADA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. MEXICO LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 39. MEXICO LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. CHINA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. CHINA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 57. CHINA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CHINA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. INDIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 61. INDIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. INDIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. JAPAN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 69. JAPAN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. JAPAN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. THAILAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 93. THAILAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. THAILAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 106. DENMARK LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. DENMARK LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. EGYPT LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 110. EGYPT LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. EGYPT LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. FINLAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 114. FINLAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. FINLAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. FRANCE LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 118. FRANCE LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 122. GERMANY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ITALY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 130. ITALY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NORWAY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 142. NORWAY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NORWAY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. POLAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. POLAND LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 146. POLAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. POLAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. QATAR LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. QATAR LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 150. QATAR LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. QATAR LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 166. SPAIN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. TURKEY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 178. TURKEY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. TURKEY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. LEUKAPHERESIS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. LEUKAPHERESIS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. LEUKAPHERESIS MARKET LICENSE & PRICING

Companies Mentioned

  • Allcells, LLC
  • Asahi Kasei Corporation
  • Beijing Zksk Technology Co. Ltd.
  • Bioivt
  • Caltag Medsystems Limited
  • Charles River Laboratories International, Inc.
  • Discovery Life Sciences
  • Fresenius Se & Co. Kgaa
  • Guangzhou Daji Medical Science and Technology Co. Ltd.
  • Haemonetics Corporation
  • Intelligent Tissue Group
  • Lonza Group Ag
  • Macopharma Sa
  • Medica Spa.
  • Miltenyi Biotec
  • Precision for Medicine, Inc.
  • Puriblood Medical Co. Ltd.
  • Stemexpress, LLC
  • Terumo BCT
  • Zenbio, Inc.

Methodology

Loading
LOADING...